Oct 2026· Frontiers in Genetics· Vol 17· 0 citations· 40 references
TL;DR
Functional RNA evidence for a recurrent non-canonical intronic splice variant is provided and a molecular diagnosis of PCH2D is established, strengthening the importance of transcript-level analyses for interpreting intronic variants and improving diagnosis in ultra-rare neurodevelopmental disorders.
Abstract
Pontocerebellar hypoplasia type 2D (PCH2D, OMIM #613811) is an ultra-rare autosomal recessive neurodevelopmental disorder caused by biallelic pathogenic variants in
SEPSECS
, which encodes a key enzyme required for selenoprotein biosynthesis. An extensive literature review conducted for this report identified approximately 34 genetically confirmed patients from 26 families with
SEPSECS
-related disease across the published literature, underscoring the extreme rarity of PCH2D. Intronic splice-altering variants with functional RNA confirmation remain poorly characterized, and no population-specific founder variant has been established for
SEPSECS
-related PCH2D.
We performed detailed clinical, molecular, and transcriptomic analyses in three affected individuals from two unrelated Acadian families originating from the Canadian Maritime provinces. All individuals underwent exome sequencing, followed by RNA-based analyses of patient-derived samples to assess the functional impact of the recurrent intronic
SEPSECS
variant.
Exome sequencing identified the same homozygous intronic
SEPSECS
variant, c.388 + 3A>G, in all three affected individuals. The variant was initially classified as a variant of uncertain significance in patients 1 and 2 and as likely pathogenic in patient 3 by different diagnostic laboratories. RNA analysis demonstrated aberrant splicing with exon 3 skipping, generating an out-of-frame transcript consistent with a loss-of-function mechanism. Residual normally spliced transcript was also detected in blood-derived RNA, consistent with a partial or “leaky” splice defect at the transcript level. These findings supported pathogenic reclassification and established a molecular diagnosis of PCH2D. Clinically, the patients presented with early-onset lower-extremity spasticity, gait abnormalities, nystagmus, and mild neurodevelopmental delay, but had an attenuated clinical course compared to classical severe PCH2D.
This case series expands the molecular and clinical spectrum of
SEPSECS
-related PCH2D by providing functional RNA evidence for a recurrent non-canonical intronic splice variant and documenting an attenuated infantile-onset presentation. The recurrence of c.388 + 3A>G in individuals of Acadian ancestry raises the possibility of a candidate Acadian founder allele. These findings underscore the importance of transcript-level analyses for interpreting intronic variants and improving diagnosis in ultra-rare neurodevelopmental disorders.
It is demonstrated that intronic variants in FGFR1 are a possible cause of CHH and can lead to diverse clinical phenotypes ranging from normosmic CHH to severe Kallmann syndrome, including significant presentation in female patients.
M. Yacobi-Bach, Rona Hagin, Bar Levy Lando et al.· Journal of the Endocrine Soc...· 0 citations
Pathogenic variants in MITF (Microphthalmia Transcription Factor) gene are associated with a spectrum of disorders, including Waardenburg syndrome type II and Tietz syndrome. Rare reports suggest that biallelic loss-of-function variants may result in a severe multisystem phenotype. We report an infant presenting with a...
Andreas Pampanos, Anastasia-E Kostantinidou, Maria Tzetis et al.· Clinical Genetics· 0 citations
Background: Achondrogenesis type 1A (ACG1A) is a rare perinatally lethal skeletal dysplasia that results from biallelic loss-of-function variants in TRIP11, which encodes the Golgi microtubule-associated protein GMAP-210. A case of clinically suspected ACG1A in an unrelated couple is described after termination at 19 w...
Sayan Biswas, Neelu Rajkumar Sontakke, P. Joy et al.· Journal of Reproduction &...· 0 citations
PURPOSE
SLC26A2-related skeletal dysplasias range from recessive multiple epiphyseal dysplasia (rMED) to lethal atelosteogenesis type 2, but factors underlying clinical variability are not fully defined. This study aimed to delineate genotype-phenotype correlations and identify disease modifiers in the largest cohort r...
Daria Gorodilova, T. Markova, V. Kenis et al.· Genetics in Medicine· 0 citations
Whole-genome sequencing combined with functional splicing validation is essential for resolving molecularly undiagnosed cases of WMS4, particularly when deep intronic variants are suspected, and supports clinical genetic testing and genetic counseling of hereditary connective tissue disorders.
W. Ku, Yi-Feng Xu, S. Jiao et al.· Laboratory investigation; a...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.